Description
Midodrine, an oral alpha-1 adrenergic agonist, Antihypertensive & Vasopressor has approval by the United States Food Drug Administration (FDA) for the treatment of symptomatic orthostatic hypotension. Midodrine is a prodrug that is metabolized to form desglymidodrine
Midodrine 2.5 mg
- Post Dialytic orthostatic hypotension
- Permanent Hypotension in Dialysis
- Intradialytic Hypotension
Midodrine is well tolerated, safe, and has very few adverse side effects.
Midodrine could be an effective drug for the treatment of hypotension in dialysis.
Midodrine could be an effective drug for the treatment of hypotension in dialysis.
Midodrine is able to blunt the blood pressure drop during dialysis.
The usual starting dose is 2.5mg 2 – 3 times daily .The dose should be increased at intervals of 3 – 5 days until the optimal response is obtained. Most patients are controlled on doses at or below 30mg daily in divided doses. Doses should be taken in the morning, at noon and evening
